DIOSynVax
Cambridge
About DIOSynVax
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $46.5M
- Funding stage: Seed
- Last round: Grant (Mar 2022)
- Website: diosvax.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/diosynvax-110621 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.